[ 20 ] ( Table 3 ) showed a nonsignificant trend towards improved complete control of nausea (50% versus 38% with placebo) and vomiting (78% versus 71%) (i.e., primary end point was not reached).
1
—
—
[ 20 ] ( Table 3 ) showed a nonsignificant trend towards improved complete control of nausea (50% versus 38% with placebo) and vomiting (78% versus 71%) (i.e., primary end point was not reached).